What's Going On With Tonix Pharmaceuticals Shares Today?

Tonix Pharmaceuticals Holding Corp TNXP shares are trading lower by 6.03% to $2.96 during Thursday’s pre-market session. The company announced Thursday that it has regained compliance with the minimum bid price requirement for continued listing on the Nasdaq.

Tonix's shares had a closing bid price at or above $1.00 per share for a minimum of 10 consecutive business days, which means Tonix's stock had regained compliance with the minimum bid price requirement of $1.00 per share for continued listing on the Nasdaq.

Tonix on Monday, May 16 announced that it will implement a 1-for-32 reverse stock split of its outstanding common stock. This split became effective for trading purposes as of the commencement of trading on May 17.

See Also: Why C3.Ai Shares Are Getting Hammered Today

Tonix Pharmaceuticals is a clinical-stage biopharmaceutical company.

According to data from Benzinga Pro, Tonix Pharmaceuticals has a 52-week high of $45.44 and a 52-week low of $1.91.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Penny StocksMoversTrading Ideaswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!